Emerging growth research initiates coverage on sbc medical group holdings, inc. with buy-extended rating and $9.00 price target

New york, new york--(newsfile corp. - september 4, 2025) - emerging growth research today announced the initiation of coverage on sbc medical group holdings, inc. (nasdaq: sbc) with a buy-extended rating and a 12-month price target of $9.00, more than double the company's recent closing price of $4.06. the initiation report highlights sbc's dominant position in japan's cosmetic treatment industry, its strong cash position, and growing global expansion strategy, while also acknowledging near-term revenue pressures due to pricing competition in the domestic market.
SBC Ratings Summary
SBC Quant Ranking